InvestorsHub Logo

curber

03/15/10 12:39 PM

#2266 RE: satelliteguy #2265

This PR shows that the NPC treatment has gone international, I like the last line

NPC is one of at least 42 rare, fatal diseases which are classed as lysosomal storage diseases (LSD[color=red][/color]). The enormous medical interest generated by the ameliorative results as achieved in treating NPC has brought these other rare diseases into the limelight giving hope that they, too, can benefit from Cyclo(TM) use.

uw86

03/15/10 12:42 PM

#2267 RE: satelliteguy #2265

sounds good; biased but may not see much selling for awhile given our small cap-thanks

sashex001

03/15/10 12:43 PM

#2268 RE: satelliteguy #2265

I like the idea of the press releases, but it dose not take a telepath to understand what today's PR means.

Judging by the actions illustrated in the PR CTDH is 100% certain that the FDA decision will be positive. That fact alone makes the stock gold.

Can't wait to see the 10Q I am all about the meat.

cyclone101

03/15/10 12:43 PM

#2269 RE: satelliteguy #2265

nice, thnx for the effort and report -- would love to break in to the 18's then BANG -- pr more solid news

octagramt

03/15/10 2:11 PM

#2276 RE: satelliteguy #2265

needs to cross and hold above .20 to justify an add-on based on techicals, while .05-.10 is more preferable based on a time-frame focused on the FDA decision and beyond that event, which I feel the real money is.